Camoteskimab

camoteskimab · Apollo Therapeutics Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Camoteskimab, covering 2025-09-18 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]